UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 830

Sortiert nach

Toward a new vaccine for pertussis

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (9), p.3213-3216

2014

Link zum Volltext

Verfügbarkeit prüfen

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Clinical and Vaccine Immunology, 2011-05, Vol.18 (5), p.730-735

2011

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates

Proceedings of the National Academy of Sciences - PNAS, 2009-05, Vol.106 (19), p.7974-7978

2009

Link zum Volltext

Verfügbarkeit prüfen

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2

Proceedings of the National Academy of Sciences - PNAS, 2011-11, Vol.108 (44), p.17871-17875

2011

Link zum Volltext

Verfügbarkeit prüfen

Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice

Proceedings of the National Academy of Sciences - PNAS, 2007-09, Vol.104 (36), p.14478-14482

2007

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Escherichia coli O157 O-Specific Polysaccharide Conjugate Vaccine in 2–5-Year-Old Children

The Journal of infectious diseases, 2006-02, Vol.193 (4), p.515-521

2006

Link zum Volltext

Verfügbarkeit prüfen

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus

Vaccine, 2009-10, Vol.27 (44), p.6234-6238

2009

Link zum Volltext

Verfügbarkeit prüfen

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine

Proceedings of the National Academy of Sciences - PNAS, 2011-03, Vol.108 (10), p.4087-4092

2011

Link zum Volltext

Verfügbarkeit prüfen

Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25

Proceedings of the National Academy of Sciences - PNAS, 2007-01, Vol.104 (1), p.293-298

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease

Carbohydrate research, 2011-09, Vol.346 (12), p.1551-1563

2011

Link zum Volltext

Verfügbarkeit prüfen

A mAb Recognizing a Surface Antigen of Mycobacterium tuberculosis Enhances Host Survival

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (26), p.15688-15693

1998

Link zum Volltext

Verfügbarkeit prüfen

Poly(γ-D-Glutamic Acid) Protein Conjugates Induce IgG Antibodies in Mice to the Capsule of Bacillus anthracis: A Potential Addition to the Anthrax Vaccine

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (15), p.8945-8950

2003

Link zum Volltext

Verfügbarkeit prüfen

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience

Vaccine, 2013-10, Vol.31 (45), p.5178-5191

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

Clinical and Vaccine Immunology, 2012-02, Vol.19 (2), p.140-145

2012

Link zum Volltext

Verfügbarkeit prüfen

bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (3), p.1172-1177

2010

Link zum Volltext

Verfügbarkeit prüfen

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

The New England journal of medicine, 2003-10, Vol.349 (14), p.1390-1391

2003

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice

Vaccine, 2017-09, Vol.35 (37), p.4990-4996

2017

Link zum Volltext

Verfügbarkeit prüfen

Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component

Proceedings of the National Academy of Sciences - PNAS, 2008-06, Vol.105 (25), p.8709-8712

2008

Link zum Volltext

Verfügbarkeit prüfen

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

Vaccine, 2010-03, Vol.28 (10), p.2231-2235

2010

Link zum Volltext

Verfügbarkeit prüfen

Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-γ-D-Glutamic Acid-Protein Conjugates

Infection and Immunity, 2006-08, Vol.74 (8), p.4744-4749

2006

Link zum Volltext

Verfügbarkeit prüfen

Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis

The New England journal of medicine, 2002-02, Vol.346 (7), p.491-496

2002

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Serum Bactericidal Antibody Assays for Haemophilus influenzae Serotype a

Clinical and Vaccine Immunology, 2011-02, Vol.18 (2), p.243-247

2011

Link zum Volltext

Verfügbarkeit prüfen

Erratum to ‘Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children’ [Vaccine 28 (2010) 2231–2235]

Vaccine, 2019-08, Vol.37 (36), p.5504-5504

2019

Link zum Volltext

Verfügbarkeit prüfen

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

Infection and Immunity, 2004-11, Vol.72 (11), p.6586-6588

2004

Link zum Volltext

Verfügbarkeit prüfen

Mass Vaccination of Children with Pertussis Toxoid—Decreased Incidence in Both Vaccinated and Nonvaccinated Persons

Clinical infectious diseases, 2001-10, Vol.33 (7), p.1004-1009

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 830

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(778)
Mit Volltextzugriff
(712)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(564)
Life Sciences & Biomedicine
(483)
Humans
(422)
Female
(259)
Biological And Medical Sciences
(241)
Male
(222)
Medical Sciences
(174)
Animals
(171)
Adult
(144)
Aged
(121)
Middle Aged
(119)
Immunology
(109)
Infectious Diseases
(105)
Microbiology
(95)
Fundamental And Applied Biological Sciences. Psychology
(84)
Mice
(72)
Adolescent
(62)
General & Internal Medicine
(58)
Physical Sciences
(57)
Child, Preschool
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Toward a new vaccine for pertussis

The Vi Conjugate Typhoid Vaccine Is Safe, Elicits Protective Levels of IgG Anti-Vi, and Is Compatible with Routine Infant Vaccines

Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates

Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2

Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice

Safety and Immunogenicity of Escherichia coli O157 O-Specific Polysaccharide Conjugate Vaccine in 2–5-Year-Old Children

Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus

Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine

Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25

Synthesis and antigenicity of BBGL-2 glycolipids of Borrelia burgdorferi, the causative agent of Lyme disease

A mAb Recognizing a Surface Antigen of Mycobacterium tuberculosis Enhances Host Survival

Poly(γ-D-Glutamic Acid) Protein Conjugates Induce IgG Antibodies in Mice to the Capsule of Bacillus anthracis: A Potential Addition to the Anthrax Vaccine

Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults—A review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience

Phase 1 Study of a Recombinant Mutant Protective Antigen of Bacillus anthracis

bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates

Persistent Efficacy of Vi Conjugate Vaccine against Typhoid Fever in Young Children

Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice

Saccharides cross-reactive with Bacillus anthracis spore glycoprotein as an anthrax vaccine component

Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children

Additional Conjugation Methods and Immunogenicity of Bacillus anthracis Poly-γ-D-Glutamic Acid-Protein Conjugates

Use of a Staphylococcus aureus Conjugate Vaccine in Patients Receiving Hemodialysis

Evaluation of Serum Bactericidal Antibody Assays for Haemophilus influenzae Serotype a

Erratum to ‘Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1–4-year-old Israeli children’ [Vaccine 28 (2010) 2231–2235]

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

Mass Vaccination of Children with Pertussis Toxoid—Decreased Incidence in Both Vaccinated and Nonvaccinated Persons

Suchergebnisse filtern